Also, high expression of RACGAP1 is supposed to be not only a strong poor prognostic marker in luminal-like breast cancer but might also be a predictor of response to treatment with tamoxifen and adjuvant chemotherapy (Milde-Langosch et al., 2013). Here, RACGAP1 is linked to breast carcinoma.